KORU Medical Systems Inc (KRMD)
NASDAQ
Fin d'année 31 Décembre 2023 | 2017 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -6.46 | 10.372 | 9.19 | 4.618 | -4.505 | -11.237 | -20.714 | -38.82 |
Return on Equity (%) | -7.757 | 12.617 | 10.955 | 5.585 | -5.115 | -12.56 | -25.539 | -53.177 |
Return on Invested Capital (%) | -7.509 | 11.439 | 10.957 | 5.053 | -5.149 | -14.662 | -28.019 | -58.774 |
Operating Margin (%) | -6.304 | 9.824 | 6.782 | 3.005 | -4.939 | -27.097 | -38.267 | -34.27 |
Net Profit Margin (%) | -4.352 | 6.797 | 5.25 | 2.435 | -5.013 | -19.425 | -31.047 | -48.184 |
Book Value Per Share | 0.165 | 0.189 | 0.218 | 0.264 | 0.816 | 0.8 | 0.672 | 0.429 |
Earnings Per Share | -0.014 | 0.024 | 0.024 | 0.014 | -0.028 | -0.102 | -0.191 | -0.301 |
Cash Per Share | 0.088 | 0.105 | 0.098 | 0.149 | 0.631 | 0.568 | 0.383 | 0.251 |
Working Capital Per Share | 0.143 | 0.167 | 0.195 | 0.24 | 0.783 | 0.729 | 0.503 | 0.346 |
Operating Profit Per Share | 0.2 | 0.214 | 0.283 | 0.376 | 0.345 | 0.308 | 0.338 | 0.366 |
EBIT Per Share | -0.021 | 0.034 | 0.031 | 0.018 | -0.028 | -0.143 | -0.235 | -0.214 |
EBITDA Per Share | -0.021 | 0.034 | 0.031 | 0.018 | -0.028 | -0.143 | -0.235 | -0.214 |
Free Cash Flow Per Share | -0.011 | 0.023 | 0.028 | 0.016 | -0.013 | -0.104 | -0.142 | -0.302 |
Fin d'année 31 Décembre 2023 | 2017 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 37,82M | 37,99M | 38,2M | 39,5M | 43,26M | 44,62M | 45,44M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 45,44M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -40.417 | N/A | N/A | N/A | -23.616 | N/A | N/A |
Net Profit Margin (%) | N/A | -32.612 | N/A | N/A | N/A | -23.616 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 201,68M |
Ratio cours/bénéfice | -13,34 |
Ratio prix/ventes | 6,43 |
Ratio prix/liquidités | 15,97 |
Ratio prix/valeur comptable | 9,01 |
Rendement de dividende | - |
Actions en circulation | 45,84M |
Volume moyen (1 semaine) | 80,63k |
Volume moyen (1 mois) | 65,45k |
Variation sur 52 semaines | 99,57% |
Plus haut sur 52 semaines | 4,63 |
Plus bas sur 52 semaines | 1,9783 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales